5% stakes
Caligan Partners
Institution
- 5% stake reports
- 20
- 5% stake stocks
- 9
- Latest report
- 26/08/14
5% stake reports
| Stock | ||
|---|---|---|
| SAB Biotherapeutics SABS08/14 | 8.8%7,967,207 sh | −1.6pp |
| Avalo Therapeutics AVTX08/14 | 5.9%3,163,866 sh | −1.3pp |
| Opus Genetics IRD08/14 | 7.3%6,077,084 sh | −1.2pp |
| Faeth Therapeutics FTH08/14 | 2.4%629,467 sh | −7.0pp |
| Cellectar Biosciences CLRB08/14 | 5.9%469,998 sh | First report |
| SAB Biotherapeutics SABS05/15 | 10.4%7,967,207 sh | First report |
| Opus Genetics IRD05/15 | 8.5%6,075,028 sh | First report |
| LB Pharmaceuticals LBRX05/15 | 5%1,438,070 sh | First report |
| Avalo Therapeutics AVTX05/15 | 7.2%1,635,023 sh | +2.3pp |
| Faeth Therapeutics FTH05/15 | 9.4%126,002 sh | First report |
| Avalo Therapeutics AVTX02/17 | 4.9%881,533 sh | −1.4pp |
| Evolus EOLS02/17 | 0%0 sh | −6.4pp |
| Anika Therapeutics ANIK01/27 | 9.95%1,435,130 sh | +0.0pp |
| Verrica Pharmaceuticals VRCA25/12/30 | 9.99%6,503,054 sh | +0.0pp |
| Verrica Pharmaceuticals VRCA25/11/24 | 9.99%6,503,054 sh | +0.0pp |
| Anika Therapeutics ANIK25/11/21 | 9.95%1,435,130 sh | No earlier report |
| Avalo Therapeutics AVTX25/11/14 | 6.3%833,333 sh | First report |
| Evolus EOLS25/11/14 | 6.4%4,138,943 sh | +1.2pp |
| Evolus EOLS25/08/14 | 5.2%3,341,970 sh | First report |
| Verrica Pharmaceuticals VRCA25/02/12 | 9.99%15,856,653 sh | First report |
